• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Polyglucosan body structure in Lafora disease.Lafora 病中的多聚葡聚糖体结构。
Carbohydr Polym. 2020 Jul 15;240:116260. doi: 10.1016/j.carbpol.2020.116260. Epub 2020 Apr 14.
2
Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.Lafora 病中星形胶质细胞和神经元产生不同类型的多聚葡聚糖体。
Glia. 2018 Oct;66(10):2094-2107. doi: 10.1002/glia.23463. Epub 2018 Aug 26.
3
Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.糖原合酶下调可挽救鼠 RBCK1 缺陷的支链淀粉沉积症。
Brain. 2022 Jul 29;145(7):2361-2377. doi: 10.1093/brain/awac017.
4
AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models.AAV 介导的人工 miRNA 减少成年多聚糖体和拉佛拉病小鼠模型中的致病性多聚糖体和神经炎症。
Neurotherapeutics. 2022 Apr;19(3):982-993. doi: 10.1007/s13311-022-01218-7. Epub 2022 Mar 28.
5
Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.拉弗拉宁可防止应激诱导的多聚葡聚糖体形成和拉佛拉病神经元进展。
Mol Neurobiol. 2013 Aug;48(1):49-61. doi: 10.1007/s12035-013-8438-2. Epub 2013 Apr 2.
6
Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.拉福林优先结合神经毒性淀粉样多葡聚糖,在进行性肌阵挛性癫痫中,这种多葡聚糖在没有拉福林的情况下形成。
Hum Mol Genet. 2004 Jun 1;13(11):1117-29. doi: 10.1093/hmg/ddh130. Epub 2004 Apr 21.
7
The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.拉福拉病蛋白的碳水化合物结合结构域靶向拉福拉多聚葡萄糖体。
Biochem Biophys Res Commun. 2004 Jan 23;313(4):1101-9. doi: 10.1016/j.bbrc.2003.12.043.
8
Accumulation of Laforin and Other Related Proteins in Canine Lafora Disease With EPM2B Repeat Expansion.伴有EPM2B重复扩增的犬Lafora病中Laforin及其他相关蛋白的积累。
Vet Pathol. 2018 Jul;55(4):543-551. doi: 10.1177/0300985818758471. Epub 2018 Feb 14.
9
Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.靶向拉罗汤加病致病性 Lafora 体的抗体酶融合物。
Cell Metab. 2019 Oct 1;30(4):689-705.e6. doi: 10.1016/j.cmet.2019.07.002. Epub 2019 Jul 25.
10
Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice.Lafora 小体的发生发展和 Laforin 缺乏小鼠神经细胞骨架的变化。
Exp Neurol. 2012 Jul;236(1):131-40. doi: 10.1016/j.expneurol.2012.04.008. Epub 2012 Apr 19.

引用本文的文献

1
Neuromuscular junction dysfunction in Lafora disease.拉佛拉病中的神经肌肉接头功能障碍。
Dis Model Mech. 2024 Oct 1;17(10). doi: 10.1242/dmm.050905. Epub 2024 Oct 14.
2
Neurological glycogen storage diseases and emerging therapeutics.神经糖原贮积病和新兴治疗方法。
Neurotherapeutics. 2024 Sep;21(5):e00446. doi: 10.1016/j.neurot.2024.e00446. Epub 2024 Sep 14.
3
Effect of intracerebroventricular administration of alglucosidase alfa in two mouse models of Lafora disease: Relevance for clinical practice.脑室内给予阿加糖酶α在两种拉佛拉病小鼠模型中的作用:与临床实践的相关性。
Epilepsy Res. 2024 Feb;200:107317. doi: 10.1016/j.eplepsyres.2024.107317. Epub 2024 Feb 6.
4
Gys1 Antisense Therapy Prevents Disease-Driving Aggregates and Epileptiform Discharges in a Lafora Disease Mouse Model.Gys1 反义疗法可预防拉佛拉病小鼠模型中的致病聚集物和癫痫样放电。
Neurotherapeutics. 2023 Oct;20(6):1808-1819. doi: 10.1007/s13311-023-01434-9. Epub 2023 Sep 12.
5
Analyzing the Virchow pioneering report on brain corpora amylacea: shedding light on recurrent controversies.分析 Virchow 关于脑髓质淀粉样体的开创性报告:揭示反复出现的争议。
Brain Struct Funct. 2023 Jul;228(6):1371-1378. doi: 10.1007/s00429-023-02664-5. Epub 2023 Jun 26.
6
Polyglucosan body disease in an aged chimpanzee (Pan troglodytes).老年黑猩猩(Pan troglodytes)的多聚糖体病。
Neuropathology. 2023 Dec;43(6):463-471. doi: 10.1111/neup.12906. Epub 2023 Apr 21.
7
Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders.星形胶质细胞在拉佛拉病和其他糖原贮积症的病理生理学中的作用。
Cells. 2023 Feb 24;12(5):722. doi: 10.3390/cells12050722.
8
Wasteosomes () as a hallmark of chronic glymphatic insufficiency.溶酶体(Wasteosomes)是慢性糖质内稳态不足的一个标志。
Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2211326119. doi: 10.1073/pnas.2211326119. Epub 2022 Nov 21.
9
Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies.基因治疗:针对单基因癫痫的新方法。
Front Neurol. 2022 Jun 21;13:805007. doi: 10.3389/fneur.2022.805007. eCollection 2022.
10
Lafora Disease and Alpha-Synucleinopathy in Two Adult Free-Ranging Moose () Presenting with Signs of Blindness and Circling.两只成年野生驼鹿出现失明和转圈症状,患拉福拉病和α-突触核蛋白病
Animals (Basel). 2022 Jun 25;12(13):1633. doi: 10.3390/ani12131633.

本文引用的文献

1
The 5th International Lafora Epilepsy Workshop: Basic science elucidating therapeutic options and preparing for therapies in the clinic.第五届国际拉福拉癫痫研讨会:基础科学阐明治疗选择并为临床治疗做准备。
Epilepsy Behav. 2020 Feb;103(Pt A):106839. doi: 10.1016/j.yebeh.2019.106839. Epub 2020 Jan 10.
2
Accurate and sensitive quantitation of glucose and glucose phosphates derived from storage carbohydrates by mass spectrometry.通过质谱法对来源于储存碳水化合物的葡萄糖和葡萄糖磷酸盐进行准确且灵敏的定量分析。
Carbohydr Polym. 2020 Feb 15;230:115651. doi: 10.1016/j.carbpol.2019.115651. Epub 2019 Nov 20.
3
Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.脑糖原结构及其相关蛋白:过去、现在与未来
Adv Neurobiol. 2019;23:17-81. doi: 10.1007/978-3-030-27480-1_2.
4
Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.靶向拉罗汤加病致病性 Lafora 体的抗体酶融合物。
Cell Metab. 2019 Oct 1;30(4):689-705.e6. doi: 10.1016/j.cmet.2019.07.002. Epub 2019 Jul 25.
5
Skeletal Muscle Glycogen Chain Length Correlates with Insolubility in Mouse Models of Polyglucosan-Associated Neurodegenerative Diseases.骨骼肌糖原链长与多聚糖相关神经退行性疾病小鼠模型中的不溶性相关。
Cell Rep. 2019 Apr 30;27(5):1334-1344.e6. doi: 10.1016/j.celrep.2019.04.017.
6
Exploring the elusive composition of corpora amylacea of human brain.探索人脑齿状核的难以捉摸的组成成分。
Sci Rep. 2018 Sep 10;8(1):13525. doi: 10.1038/s41598-018-31766-y.
7
Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.Lafora 病中星形胶质细胞和神经元产生不同类型的多聚葡聚糖体。
Glia. 2018 Oct;66(10):2094-2107. doi: 10.1002/glia.23463. Epub 2018 Aug 26.
8
Lafora disease offers a unique window into neuronal glycogen metabolism.拉佛拉病为神经元糖原代谢提供了一个独特的窗口。
J Biol Chem. 2018 May 11;293(19):7117-7125. doi: 10.1074/jbc.R117.803064. Epub 2018 Feb 26.
9
Astrocytes: new players in progressive myoclonus epilepsy of Lafora type.星形胶质细胞:Lafora 型进行性肌阵挛癫痫的新角色。
Hum Mol Genet. 2018 Apr 1;27(7):1290-1300. doi: 10.1093/hmg/ddy044.
10
Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.拉福拉病的发病机制:可溶性糖原向不溶性多聚葡萄糖的转变。
Int J Mol Sci. 2017 Aug 11;18(8):1743. doi: 10.3390/ijms18081743.

Lafora 病中的多聚葡聚糖体结构。

Polyglucosan body structure in Lafora disease.

机构信息

Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, KY, 40536, USA; Lafora Epilepsy Cure Initiative, Epilepsy and Brain Metabolism Center, and Center for Structural Biology, University of Kentucky College of Medicine, Lexington, KY, 40536, USA; Institute for Research in Biomedicine (IRB Barcelona), 08028, Barcelona, Spain.

Univ. Grenoble Alpes, CNRS, CERMAV, F-38000, Grenoble, France.

出版信息

Carbohydr Polym. 2020 Jul 15;240:116260. doi: 10.1016/j.carbpol.2020.116260. Epub 2020 Apr 14.

DOI:10.1016/j.carbpol.2020.116260
PMID:32475552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7266828/
Abstract

Abnormal carbohydrate structures known as polyglucosan bodies (PGBs) are associated with neurological disorders, glycogen storage diseases (GSDs), and aging. A hallmark of the GSD Lafora disease (LD), a fatal childhood epilepsy caused by recessive mutations in the EPM2A or EPM2B genes, are cytoplasmic PGBs known as Lafora bodies (LBs). LBs result from aberrant glycogen metabolism and drive disease progression. They are abundant in brain, muscle and heart of LD patients and Epm2a and Epm2b mice. LBs and PGBs are histologically reminiscent of starch, semicrystalline carbohydrates synthesized for glucose storage in plants. In this study, we define LB architecture, tissue-specific differences, and dynamics. We propose a model for how small polyglucosans aggregate to form LBs. LBs are very similar to PGBs of aging and other neurological disorders, and so these studies have direct relevance to the general understanding of PGB structure and formation.

摘要

异常的碳水化合物结构,称为多聚糖体 (PGBs),与神经紊乱、糖原贮积疾病 (GSDs) 和衰老有关。GSD 拉佛拉病 (LD) 的一个特征是细胞质 PGBs,称为拉佛拉体 (LBs),这是一种由 EPM2A 或 EPM2B 基因突变引起的致命儿童癫痫。LBs 是由异常的糖原代谢引起的,并导致疾病的进展。它们在 LD 患者的大脑、肌肉和心脏以及 Epm2a 和 Epm2b 小鼠中大量存在。LBs 和 PGBs 在组织学上类似于淀粉,这是一种半结晶的碳水化合物,用于植物的葡萄糖储存。在这项研究中,我们定义了 LB 的结构、组织特异性差异和动态。我们提出了一个关于小多聚糖如何聚集形成 LBs 的模型。LBs 与衰老和其他神经紊乱的 PGBs 非常相似,因此这些研究对于普遍理解 PGB 的结构和形成具有直接的意义。